Cargando…

Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma

PURPOSE: To seek novel diagnostic approaches, we improved the workflow of cell-free DNA (cfDNA) sequencing and evaluated its feasibility in vitreoretinal lymphoma (VRL) specimens; the profile of mutations was preliminarily analyzed for potential diagnostic value. METHODS: The study was a diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Junxiang, Jiang, Tingting, Liu, Shixue, Ping, Bo, Li, Ruiwen, Chen, Wenwen, Wang, Ling, Huang, Xin, Xu, Gezhi, Chang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343589/
https://www.ncbi.nlm.nih.gov/pubmed/35928872
http://dx.doi.org/10.3389/fonc.2022.932674
_version_ 1784761023426723840
author Gu, Junxiang
Jiang, Tingting
Liu, Shixue
Ping, Bo
Li, Ruiwen
Chen, Wenwen
Wang, Ling
Huang, Xin
Xu, Gezhi
Chang, Qing
author_facet Gu, Junxiang
Jiang, Tingting
Liu, Shixue
Ping, Bo
Li, Ruiwen
Chen, Wenwen
Wang, Ling
Huang, Xin
Xu, Gezhi
Chang, Qing
author_sort Gu, Junxiang
collection PubMed
description PURPOSE: To seek novel diagnostic approaches, we improved the workflow of cell-free DNA (cfDNA) sequencing and evaluated its feasibility in vitreoretinal lymphoma (VRL) specimens; the profile of mutations was preliminarily analyzed for potential diagnostic value. METHODS: The study was a diagnostic trial. 23 eyes of 23 patients with VRL and 25 eyes of 25 patients with inflammatory eye diseases were enrolled. Approximate 500μl undiluted vitreous humor and 10ml diluted vitreous fluid was obtained through diagnostic vitrectomy and sent for cytopathological examinations. 500μl of the diluted vitreous fluid was spared for cfDNA sequencing. For cfDNA sequencing, DNA fragmentation procedure was added to the workflow to improve the extraction efficiency; mutations detected were analyzed for potential diagnostic model. The sensitivity and specificity of the cytopathology and cfDNA sequencing were compared. The clinical manifestations were preliminarily analyzed for potential correlations with the genotypes. RESULTS: CfDNA sequencing was accomplished in 23 eyes with VRL and 20 eyes with inflammatory eye diseases. VRL-related mutated genes included MYD88 (18 eyes, 78%), ETV6 (11 eyes, 48%), PIM1 (11 eyes,48%), BTG2 (7 eyes, 30%), IRF4 (7 eyes, 30%), CD79B (6 eyes, 26%), LRP1B (6 eyes, 26%), etc. Logistic regression based on the mutations of MYD88 and ETV6 was of the potential for the diagnosis of VRL (P<0.001, adjusted R2 = 0.789, sensitivity 0.913, specificity 0.950); by comparison, the sensitivity and specificity of the vitreous cytopathology were 0.826 and 1.000, respectively. Further analysis of the mutation profile showed that patients carrying CD79B mutation tended to have higher intraocular interleukin-10 level (P=0.030), that CARD11 mutation was correlated with younger age at ocular onset (P=0.039), and that patients with intracranial involvement carried more multiple-site mutations in the BTG2 gene (P=0.013). CONCLUSIONS: The improved workflow of CfDNA sequencing is of sound feasibility in a limited amount of vitreous humor. The logistic model based on the mutations could help to provide reliable clues for the diagnosis of VRL.
format Online
Article
Text
id pubmed-9343589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93435892022-08-03 Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma Gu, Junxiang Jiang, Tingting Liu, Shixue Ping, Bo Li, Ruiwen Chen, Wenwen Wang, Ling Huang, Xin Xu, Gezhi Chang, Qing Front Oncol Oncology PURPOSE: To seek novel diagnostic approaches, we improved the workflow of cell-free DNA (cfDNA) sequencing and evaluated its feasibility in vitreoretinal lymphoma (VRL) specimens; the profile of mutations was preliminarily analyzed for potential diagnostic value. METHODS: The study was a diagnostic trial. 23 eyes of 23 patients with VRL and 25 eyes of 25 patients with inflammatory eye diseases were enrolled. Approximate 500μl undiluted vitreous humor and 10ml diluted vitreous fluid was obtained through diagnostic vitrectomy and sent for cytopathological examinations. 500μl of the diluted vitreous fluid was spared for cfDNA sequencing. For cfDNA sequencing, DNA fragmentation procedure was added to the workflow to improve the extraction efficiency; mutations detected were analyzed for potential diagnostic model. The sensitivity and specificity of the cytopathology and cfDNA sequencing were compared. The clinical manifestations were preliminarily analyzed for potential correlations with the genotypes. RESULTS: CfDNA sequencing was accomplished in 23 eyes with VRL and 20 eyes with inflammatory eye diseases. VRL-related mutated genes included MYD88 (18 eyes, 78%), ETV6 (11 eyes, 48%), PIM1 (11 eyes,48%), BTG2 (7 eyes, 30%), IRF4 (7 eyes, 30%), CD79B (6 eyes, 26%), LRP1B (6 eyes, 26%), etc. Logistic regression based on the mutations of MYD88 and ETV6 was of the potential for the diagnosis of VRL (P<0.001, adjusted R2 = 0.789, sensitivity 0.913, specificity 0.950); by comparison, the sensitivity and specificity of the vitreous cytopathology were 0.826 and 1.000, respectively. Further analysis of the mutation profile showed that patients carrying CD79B mutation tended to have higher intraocular interleukin-10 level (P=0.030), that CARD11 mutation was correlated with younger age at ocular onset (P=0.039), and that patients with intracranial involvement carried more multiple-site mutations in the BTG2 gene (P=0.013). CONCLUSIONS: The improved workflow of CfDNA sequencing is of sound feasibility in a limited amount of vitreous humor. The logistic model based on the mutations could help to provide reliable clues for the diagnosis of VRL. Frontiers Media S.A. 2022-07-19 /pmc/articles/PMC9343589/ /pubmed/35928872 http://dx.doi.org/10.3389/fonc.2022.932674 Text en Copyright © 2022 Gu, Jiang, Liu, Ping, Li, Chen, Wang, Huang, Xu and Chang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gu, Junxiang
Jiang, Tingting
Liu, Shixue
Ping, Bo
Li, Ruiwen
Chen, Wenwen
Wang, Ling
Huang, Xin
Xu, Gezhi
Chang, Qing
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma
title Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma
title_full Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma
title_fullStr Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma
title_full_unstemmed Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma
title_short Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma
title_sort cell-free dna sequencing of intraocular fluid as liquid biopsy in the diagnosis of vitreoretinal lymphoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343589/
https://www.ncbi.nlm.nih.gov/pubmed/35928872
http://dx.doi.org/10.3389/fonc.2022.932674
work_keys_str_mv AT gujunxiang cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT jiangtingting cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT liushixue cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT pingbo cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT liruiwen cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT chenwenwen cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT wangling cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT huangxin cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT xugezhi cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma
AT changqing cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma